Noile-Immune Biotech Inc. (TYO:4893)
Japan · Delayed Price · Currency is JPY 87.00
-1.00 (-1.14%)
Oct 26, 2026, 3:30 PM JST
Noile-Immune Biotech Market Cap
Noile-Immune Biotech has a market cap or net worth of 3.78 billion as of October 26, 2026. It is the 35,413th most valuable company in the world and the 3,290th biggest in Japan. Its market cap has decreased by 46.18% in one year.
Market Cap
3.78B
Enterprise Value
231.72M
Revenue
1.00M
Global Rank
Country Rank
#3,290 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 28, 2023, Noile-Immune Biotech's market cap has decreased from 30.89B to 3.78B, a decrease of -87.78%. That is a compound annual growth rate of -46.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 3.78B | -34.44% |
| Dec 30, 2025 | 5.76B | -21.76% |
| Dec 30, 2024 | 7.36B | -19.77% |
| Dec 29, 2023 | 9.17B | -70.30% |
| Jun 28, 2023 | 30.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyfuse Biomedical K.K. | 5.67B |
| BrightPath Biotherapeutics | 5.42B |
| Kringle Pharma | 5.12B |
| PRISM BioLab Co.,LTD | 4.88B |
| Kohjin Bio | 3.92B |
| Chordia Therapeutics | 3.86B |
| Ribomic | 3.73B |
| D. Western Therapeutics Institute | 3.68B |